Carbosorb X New Zealand - English - Medsafe (Medicines Safety Authority)

carbosorb x

aft pharmaceuticals ltd - charcoal, activated 15.1%{relative}; charcoal, activated 0.2 g/ml - oral suspension - 50 g - active: charcoal, activated 15.1%{relative} excipient: citric acid glycerol propylene glycol purified water sucrose active: charcoal, activated 0.2 g/ml excipient: citric acid   glycerol propylene glycol purified water sodium hydroxide sucrose - the treatment of poisoning and medicine overdose by oral ingestion.

8.4% w/v Sodium Bicarbonate Intravenous Infusion BP Ireland - English - HPRA (Health Products Regulatory Authority)

8.4% w/v sodium bicarbonate intravenous infusion bp

b. braun medical limited - sodium bicarbonate - solution for infusion - 8.4 percent weight/volume - electrolyte solutions; sodium bicarbonate

VALPRO EC500 sodium valproate 500 mg enteric coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

valpro ec500 sodium valproate 500 mg enteric coated tablet blister pack

sanofi-aventis australia pty ltd - sodium valproate, quantity: 500 mg - tablet, enteric coated - excipient ingredients: citric acid monohydrate; hypromellose; polyvinyl acetate phthalate; diethyl phthalate; purified talc; hyprolose; titanium dioxide; povidone; magnesium stearate; amaranth aluminium lake; calcium silicate; indigo carmine aluminium lake; stearic acid; macrogol 6000 - epilepsy: primary generalised epilepsy (petit mal absences, various forms of myoclonic epilepsy and tonic-clonic grand mal seizures). partial (focal) epilepsy either alone or as adjuvant therapy. mania: for the treatment of mania where other therapy has proved inadequate or is inappropriate

VALPRO EC200 sodium valproate 200 mg enteric coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

valpro ec200 sodium valproate 200 mg enteric coated tablet blister pack

sanofi-aventis australia pty ltd - sodium valproate, quantity: 200 mg - tablet, enteric coated - excipient ingredients: hypromellose; stearic acid; indigo carmine aluminium lake; purified talc; calcium silicate; citric acid monohydrate; amaranth aluminium lake; macrogol 6000; povidone; hyprolose; titanium dioxide; diethyl phthalate; polyvinyl acetate phthalate; magnesium stearate - epilepsy: primary generalised epilepsy (petit mal absences, various forms of myoclonic epilepsy and tonic-clonic grand mal seizures). partial (focal) epilepsy either alone or as adjuvant therapy. mania: for the treatment of mania where other therapy has proved inadequate or is inappropriate

VALPROATE WINTHROP EC 500 sodium valproate 500mg Tablet Australia - English - Department of Health (Therapeutic Goods Administration)

valproate winthrop ec 500 sodium valproate 500mg tablet

sanofi-aventis australia pty ltd - sodium valproate, quantity: 500 mg - tablet, enteric coated - excipient ingredients: purified talc; amaranth aluminium lake; titanium dioxide; stearic acid; magnesium stearate; macrogol 6000; indigo carmine aluminium lake; polyvinyl acetate phthalate; calcium silicate; diethyl phthalate; povidone; hypromellose; citric acid monohydrate; hyprolose - epilepsy: primary generaliszed epilepsies (petit mal absences, various forms of myoclonic epilepsies and tonic-clonic grand mal seizures). partial (focal) epilepsies either alone or as adjuvant therapy. mania: for the treatment of mania where other therapy has proved inadequate or is inappropriate.

VALPROATE WINTHROP EC 200 sodium valproate 200mg tablet Australia - English - Department of Health (Therapeutic Goods Administration)

valproate winthrop ec 200 sodium valproate 200mg tablet

sanofi-aventis australia pty ltd - sodium valproate, quantity: 200 mg - tablet, enteric coated - excipient ingredients: purified talc; magnesium stearate; titanium dioxide; stearic acid; indigo carmine aluminium lake; calcium silicate; polyvinyl acetate phthalate; hypromellose; citric acid monohydrate; diethyl phthalate; hyprolose; amaranth aluminium lake; povidone; macrogol 6000 - epilepsy: primary generalised epilepsies (petit mal absences, various forms of myoclonic epilepsies and tonic-clonic grand mal seizures). partial (focal) epilepsies either alone or as adjuvant therapy. mania: for the treatment of mania where other therapy has proved inadequate or is inappropriate.

Sodium Valproate (400mg/4ml) Solution for Inj/Inf 100mg/ml Malta - English - Medicines Authority

sodium valproate (400mg/4ml) solution for inj/inf 100mg/ml

wockhardt uk limited - valproate sodium - solution for infusion or injection - valproate sodium 100 mg/ml - antiepileptics

Sodium Valproate (1000mg/10ml) Solution for Inj/Inf 100mg/ml Malta - English - Medicines Authority

sodium valproate (1000mg/10ml) solution for inj/inf 100mg/ml

wockhardt uk limited - valproate sodium - solution for infusion or injection - valproate sodium 100 mg - antiepileptics

SODIUM VALPROATE AGUETTANT SOLUTION FOR INJECTION 400MG4ML Singapore - English - HSA (Health Sciences Authority)

sodium valproate aguettant solution for injection 400mg4ml

aguettant asia pacific pte. ltd. - sodium valproate - injection, solution - sodium valproate 400mg/4ml